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Abstract
Intensity-modulated radiation therapy (IMRT) currently plays an important role in radiother-
apy, but its treatment plan quality can vary significantly among institutions and planners.
Treatment plan quality control (QC) is a necessary component for individual clinics to
ensure that patients receive treatments with high therapeutic gain ratios. The voxel-weight-
ing factor-based plan re-optimization mechanism has been proved able to explore a larger
Pareto surface (solution domain) and therefore increase the possibility of finding an optimal
treatment plan. In this study, we incorporated additional modules into an in-house devel-
oped voxel weighting factor-based re-optimization algorithm, which was enhanced as a
highly automated and accurate IMRT plan QC tool (TPS-QC tool). After importing an under-
assessment plan, the TPS-QC tool was able to generate a QC report within 2 minutes. This
QC report contains the plan quality determination as well as information supporting the
determination. Finally, the IMRT plan quality can be controlled by approving quality-passed
plans and replacing quality-failed plans using the TPS-QC tool. The feasibility and accuracy
of the proposed TPS-QC tool were evaluated using 25 clinically approved cervical cancer
patient IMRT plans and 5 manually created poor-quality IMRT plans. The results showed
high consistency between the QC report quality determinations and the actual plan quality.
In the 25 clinically approved cases that the TPS-QC tool identified as passed, a greater dif-
ference could be observed for dosimetric endpoints for organs at risk (OAR) than for plan-
ning target volume (PTV), implying that better dose sparing could be achieved in OAR than
in PTV. In addition, the dose-volume histogram (DVH) curves of the TPS-QC tool re-opti-
mized plans satisfied the dosimetric criteria more frequently than did the under-assessment
plans. In addition, the criteria for unsatisfied dosimetric endpoints in the 5 poor-quality plans
could typically be satisfied when the TPS-QC tool generated re-optimized plans without
sacrificing other dosimetric endpoints. In addition to its feasibility and accuracy, the
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proposed TPS-QC tool is also user-friendly and easy to operate, both of which are neces-
sary characteristics for clinical use.
Introduction
Intensity-modulated radiation therapy (IMRT) has been widely accepted as a favorable treat-
ment modality for multiple types of tumors [1–5]. Compared with conventional three-dimen-
sional conformal radiotherapy (3D-CRT), IMRT can provide a higher conformal and more
uniform dose distribution to the target while minimizing the dose to the surrounding normal
tissues and organs at risk (OAR) [6–10]. An optimal plan should be created for every individual
patient to ensure the best radiotherapy treatment efficacy; however, creating an optimal IMRT
plan is complicated. Researches show that a clinically approved plan’s quality can vary signifi-
cantly, depending on how experienced the planner is, how much time the planner spends on
the plan, how difficult a particular planning job is, how good the communication between the
physician and the planner is, the institution-specific planning protocols, and a number of other
factors. [11–16]. High quality plans are hardly guaranteed for every single patient, while no
plan quality evaluation tool is available under current clinical circumstances. Therefore, a tool
that can easily and accurately conduct IMRT plan QC must be developed and afterwards
widely applied as an essential component before the final plan is submitted.
The IMRT plan creation is mainly the process of searching optimal solutions with a dose
optimization algorithm within given dosimetric goals [17–20]. Therefore, plan quality relies
heavily on how optimal the given dosimetric goals are and how well the optimization algorithm
explores the globally optimal solution. Wu et al (2009) introduced a method for quality control
by flagging plans in which the patient geometry is similar but the structure doses are worse
when matched against previous treatment plans. Subsequently, Moore et al (2011) built a
mathematical model to predict achievable OAR dose-volume histograms (DVHs) using a sub-
DVH concept. “Sub-DVH” describes the expected dose to an OAR’s sub-volume at a certain
distance from the PTV surface and could be generated using a set of previous plans. By treating
predictions as dosimetric goals, clinicians were able to improve on normal tissue sparing.
Although achievable dosimetric goals can be predicted ahead of time, a globally optimal
solution is hardly guaranteed due to the limitations of currently available optimization algo-
rithms. The solution domain is normally limited to a partial Pareto surface for current optimi-
zation algorithms in commercial treatment planning systems (TPS), which are organ-
weighting factor-based systems. When the optimization objective functions are modified to
voxel-weighting factor-based systems, the solution domain can be expanded to the entire
Pareto surface, therefore increasing the probability of finding a more optimal plan [21, 22].
Therefore, a voxel-weighting factor-based plan re-optimization algorithm can be applied to
perform IMRT plan quality control to ensure the best possible radiation treatment for each
cancer patient.
Cotrutz and Xing [21, 22] first refined the traditional organ-weighting factor-based optimi-
zation objective function to be voxel based to increase the adjustment freedom of different vol-
umes within each organ. These authors updated the optimizations iteratively and found that
better trade-offs could be achieved among planning dosimetric endpoints than among tradi-
tional models. Later, Wu et al [23] proposed their own voxel-weighting factor-based models
and mathematically proved that voxel-weighting factor-based optimization methods can care-
fully balance the trade-offs. Moreover, these authors found that re-optimizing original plans
with voxel-based objective functions is equivalent to tuning the prescription dose in certain
conditions. Later, Albin Fredriksson [24] established another voxel-weighting factor-based
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optimization model with constraints to enforce each voxel’s dose or the dose-volume histo-
gram (DVH) of each organ to be at least as good as in the reference plan. By doing this, the
original plan quality could automatically be improved.
Although the aforementioned methods have demonstrated the potential feasibility of apply-
ing voxel-weighting factor-based re-optimization algorithms to plan quality improvements,
additional issues may need to be addressed in developing practical plan QC tools. First, the
process of optimizing the algorithm search for the optimal solution is automated when certain
voxel-weighting factors are given, but the voxel-weighting factors are manually determined.
This makes it difficult to satisfy the high automation requirement for clinical application. Sec-
ond, the emphasis on the above-mentioned re-optimization methods expands the optimization
solution domain; however, the feasibility of applying these methods as a plan QC tool, such as
the efficiency and accuracy of the evaluation, are not mentioned. Based on these observations,
we incorporated additional modules and enhanced our own in-house re-optimization model to
be a highly automated and accurate IMRT plan QC tool (TPS-QC tool). After importing an
under-assessment plan, the TPS-QC tool was able to generate a potential optimal plan for the
imported plan; then, by comparing the original plan with the optimized plan, the original plan
quality could be determined. The plan quality determination is given in the form of a QC
report, which can be automatically created within 2 minutes of when a plan is imported. In
addition to the quality determination, the QC report also contains information supporting the
results. Finally, the IMRT plan quality can be controlled by approving quality-passed plans and
replacing quality-failed plans with TPS-QC-generated optimal plans.
Methods and Materials
The proposed plan QC tool was designed within SCORE (Super Computer On-line Re-plan-
ning Environment), which is an in-house IMRT re-planning system capable of plan loading,
CT to CT/CBCT rigid and deformable registration [25–27], plan re-optimization [28–32], and
dose calculation [33]. The entire system was fully implemented on a graphic processing unit
(GPU) to accelerate its performance and was developed to perform adaptive radiotherapy
(ART) re-planning [34] and automated treatment planning. To enhance the SCORE system
and make it a highly automated, effective and accurate IMRT plan QC tool, additional related
modules were implemented. The QC workflow and feasibility, as well as the determination
accuracy, were then tested and evaluated with both high- and poor-quality IMRT cases.
1. QC-related modules and integrated workflow
Additional modules, including IMRT planning protocol importation and plan quality report
generation, were appended. The IMRT planning protocol importation module aimed to build
an IMRT plan protocol database with multiple types of tumor sites and specific institution end-
point emphasis with corresponding criteria. From the user imported/chosen plan protocol,
IMRT plan dosimetric endpoints and criteria can be obtained for further plan quality evalua-
tions. Automated plan quality report generation comprised the main process and included the
following steps: 1) launch plan protocol importation and SCORE system, including plan read-
ing, plan re-optimization, leaf sequencing and final dose calculation based on the user-
imported under-assessment plan to generate a deliverable SCORE re-optimized plan; 2) extract
dosimetric endpoint values from both the under-assessment plan and the SCORE re-optimized
plan as the plan quality indicators; 3) compare every endpoint value with the aforementioned
criterion, and fill “green”/“red” when a value satisfies or does not satisfy the corresponding cri-
terion; 4) compare every endpoint value from the under-assessment plan with that from the
SCORE re-optimized plan, and mark “red” when the value poorly satisfies the criterion (here,
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less satisfaction of the value indicates lower PTV coverage or the OAR receiving a higher dose);
5) determine the under-assessment plan quality as “passed”/“failed” when performing a Wil-
coxon matched pairs signed ranks test between data arrays constructed by all endpoint values
from the under-assessment plan and the SCORE re-optimized plan (a determination of “failed”
is assigned when a significant difference is observed; otherwise, a determination of “passed” for
the quality determination is assigned to the under-assessment plan); and 6) generate a com-
plete plan quality report, including the under-assessment plan vs. the SCORE re-optimized
plan visual DVH comparison, dosimetric endpoint value table, and final plan quality
determination.
The integrated plan QC workflow is shown in Fig 1 (Fig 1). Plans needing to be evaluated
are referred to as under-assessment plans, and plans after SCORE re-optimization are called
SCORE re-optimized plans. To compare the plan quality fairly, we first re-calculated the origi-
nal clinical exported plan using the dose engine within the SCORE to obtain the under-assess-
ment plans. Before launching the re-optimization algorithm, a plan protocol should be
imported or selected from the database to emphasize plan dosimetric endpoints and criteria.
After an under-assessment plan is imported into SCORE, a SCORE re-optimized plan will be
generated automatically. The developed automatic plan quality report generation module will
then be used to give the final plan quality determination and declare whether the plan quality
is satisfactory or unsatisfactory. In addition, a SCORE re-optimized plan is offered by the
TPS-QC tool to replace the under-assessment plan when necessary. To better support the plan
quality determination, a detailed plan quality comparison is demonstrated with both DVH and
Fig 1. Workflow for the IMRT TPS-QC tool.
doi:10.1371/journal.pone.0149273.g001
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dosimetric endpoint values between the under-assessment plan and the SCORE re-optimized
plan.
2. Plan re-optimization
Plan re-optimization is one of the key steps in our proposed TPS-QC tool. In the SCORE sys-
tem, we have developed an in-house voxel-weighting factor-based IMRT plan re-optimization
model and mathematically proven its ability to explore a much larger Pareto surface than does
the traditional organ-weighting factor-based model [32, 34]. The detailed optimization objec-
tive function is formulated below:
FsðdÞ ¼
X
s2T
as
X
j2vs
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X
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those factors for voxels. Pj denotes the prescription dose for the target or threshold dose for
critical structures. Given a set of organ- and voxel-weighting factors, the optimal solution
could be obtained using a gradient projection method [28]. Two iteration loops were facilitated
in the optimization algorithm: 1) an inner loop, namely the coarse-adjusting stage, in which
the organ-weighting factors are adjusted based on the DVH difference between the calculated
plan and the reference plan; and 2) the outer loop, namely the fine-tuning stage, in which the
voxel-weighting factors are adjusted individually within one organ to obtain a more desirable
DVH.
With the help of these two iteration loops, voxel-weighting factors can be obtained automat-
ically under a reference DVH. This reference DVH constrains the newly generated plan, which
should be at least as good as the reference while reduce the OAR dose as much as possible. For
the purposes of plan QC, the reference plan chosen was the under-assessment plan itself. If the
reference plan is feasible but not Pareto-optimal, the algorithm can generate a Pareto-optimal
plan with DVHs better than those in the reference plan. The feasibility of this method has been
validated and applied to ART and automated treatment planning for different tumor sites [34].
Efficiency was achieved with a total optimization time of less than 30 sec.
Issues such as multi-leaf collimator (MLC) leaf sequencing and MLC modeling were fully
considered and implemented, and therefore, a SCORE-generated re-optimized plan is a clini-
cally deliverable IMRT plan. For dose calculation, an in-house GPU-based finite size pencil
beam (FSPB) algorithm with 3D density correction was carried out, and its accuracy was vali-
dated by comparing it with a Monte Carlo method and analytical anisotropic algorithm (AAA)
using a commercial Eclipse system (Varian Medical Systems, Palo Alto, California, US) [33].
3. TPS-QC tool evaluation
QC-related module functions and feasibility were evaluated, as were the plan quality determi-
nation efficacy and accuracy. Twenty-five clinically approved cervical cancer patient IMRT
plans from the UC San Diego Moores Cancer Center were randomly selected. The prescription
dose was 4,500 cGy for patients with intact cervix cancer and 5,040 cGy for post-operative
patients in 180 cGy daily fractions over 5–5.5 weeks. PTV and critical structures were consid-
ered to demonstrate plan quality representative organs. These critical structures included the
bowel, bladder, rectum, bone marrow and femoral head. All treatment plans were created with
the Eclipse system by experienced dosimetrists with sufficient time and effort. The Interna-
tional Evaluation of Radiotherapy Technology Effectiveness in Cervical Cancer (INTERNECC)
protocol was employed in this study as an example. The protocol-announced dosimetric end-
points and criteria are listed in detail in Table 1 (Table in S1 Protocol).
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To further verify the effectiveness and robustness of the proposed TPS-QC tool, another 5
poor-quality IMRT plans were generated to undergo the QC workflow. These generated plans
were created with very loose dose volume objects (i.e., 40%, 90% and 75% for V45Gy of bowel,
V10Gy of bone marrow and V20Gy of bone marrow, respectively) when performing the plan
optimization procedure in the Eclipse system. By doing this, we sought to verify that when the
under-assessment plans show very poor quality, the TPS-QC tool can accurately identify and
automatically improve them.
Therefore, there were 30 cervical patient IMRT plans in total with which to test the pro-
posed TPS-QC tool. After performing the plan QC function, we used a Wilcoxon matched
pairs signed ranks test to analyze the significant difference between the under-assessment plan
and the new SCORE plan quality. Plan quality was reflected by the extracted dosimetric end-
point value array.
Results
1. Plan QC report
For each under-assessment IMRT plan, a specific QC report was generated that compared the
results to the new SCORE re-optimized plan. This report contains two parts: the comparison
details and the plan quality determination. The quality comparison details between the under-
assessment IMRT plan and the SCORE re-optimized plan are presented in terms of DVH and
plan dosimetric endpoint values for every PTV and OAR. Plan dosimetric endpoint values are
filled in green when the protocol-announced criterion is satisfied; otherwise, these values are
filled in red. In addition, the under-assessment plan dosimetric endpoint values are marked in
red when further improvement could be made after comparison with the SCORE re-optimized
plan; otherwise, they are marked in black.
Table 1. Dosimetric endpoints and criteria for assessing IMRT plan quality.
organs endpoints criteria
V99 > = 90%
V90 > = 99%
PTV V97 > = 97%
V115 <1%
V110 <10%
Dmax_overall In PTV
OAR
Bowel V45Gy <250cc
Dmax <115%
Rectum Dmax <115%
Bone Marrow V10Gy <90%
V20Gy <75%
Bladder Dmax <115%
Femoral Head Dmax <115%
Abbreviations:
Vx = percentage volume receiving x% of prescription dose
Dmax_overall = maximum dose in plan
Vx Gy = percentage volume receiving x Gy
Dmax = maximum dose in each organ; cc = cm
3
doi:10.1371/journal.pone.0149273.t001
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The entire QC process was completed within 2 minutes for each case. Protocol importation,
QC report generation and other QC-related modules worked well and were completed within
seconds. The QC report can be viewed as a PDF file and saved when necessary. The SCORE re-
optimized plan is generated automatically and can be exported to replace the under-assessment
plan when poor quality is identified.
2. Evaluation of clinically approved plans
Fig 2 illustrates a QC report example from one clinical cervical cancer IMRT case (Fig 2). In
this report, green was filled for all dosimetric endpoints from both the under-assessment plan
and the SCORE re-optimized plan, indicating that both plans effectively satisfied the protocol
criteria. Moreover, red was marked for several dosimetric endpoint values of the under-assess-
ment plan, including V45Gy and Dmax of the bowel, V20Gy of the bone marrow and Dmax of the
femoral head, indicating that further dose sparing could be obtained for these particular dosi-
metric endpoints after re-optimization. The overall p value between the under-assessment plan
and the SCORE re-optimized plan dosimetric endpoint value array was greater than 0.05,
showing no significant difference and indicating that the under-assessment plan quality passed,
although several dosimetric endpoints could be further improved.
The same processes were conducted for the other 24 clinically approved cervical cancer
IMRT plans, and a QC report was generated for each one. The results showed that the overall p
value for each under-assessment plan and SCORE re-optimized plan dosimetric endpoint
value array pair was mostly greater than 0.05, showing no significant difference and indicated
that the plan quality passed; unless one of them with a p value of 0.047(case “Clinic010”), less
than 0.05, demonstrating significant difference (detailed data could be seen in the S1 Dataset,
sheet “WilcoxonTestForClinicalPlans”).
For this particular clinically approved but with “failed” plan quality case, all dosimetric end-
points from both the under-assessment plan and the SCORE re-optimized plan satisfied the
protocol criteria. Meanwhile, most dosimetric endpoint values of the under-assessment plan
were improved after re-optimized, including V99 of the PTV, from 95.6% to 96.8% for original
plan and after re-optimization respectively; Dmax of the bowel, from 108.4% to 103.2%; Dmax of
the rectum, from 105.6% to 103.7%; V10Gy and V20Gy of the bone marrow, from 84.4% and
68.2% to 83.6% and 66.1% respectively, Dmax of the bladder, from 108.9% to 104.5% and Dmax
of the femoral head, from 98.5% to 66.5%. The scatter plot of p values obtained for the 25 clini-
cal approved cervical cancer IMRT plans can be seen in Fig 3 (Fig 3). The mean p value was
0.282, and the standard variance was 0.222.
Although the plan quality passed for most of these 25 clinically approved cervical cancer
IMRT plans, a larger difference was more frequently obtained for the OAR dosimetric end-
points than for the PTVs, implying that better dose sparing may be achieved in OAR than in
PTVs. Moreover, the DVH curves of the SCORE re-optimized plans satisfied the dosimetric
criteria more frequently than did the under-assessment plans, which indicates the better quality
of the SCORE re-optimized plans and also the opportunity for improvement of the under-
assessment IMRT plans.
3. Evaluation of poor-quality plans
The TPS-QC tool also processed the 5 manually generated poor-quality cervical cancer patient
IMRT plans. Fig 4 illustrates a QC report derived from one of those plans (Fig 4). In this report,
four dosimetric endpoint criteria were not satisfied for the under-assessment plan and are filled
in red, namely, V45Gy and Dmax of the bowel and V10Gy and V20Gy of the bone marrow. For the
corresponding SCORE re-optimized plan, these unsatisfied dosimetric endpoints became
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satisfactory without sacrificing the performance of any other dosimetric endpoints. More spe-
cifically, the dosimetric endpoints were reduced by 247.4 cc and 21.8% of the prescription dose
Fig 2. A QC report example for one clinically approved cervical cancer IMRT plan.
doi:10.1371/journal.pone.0149273.g002
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for bowel V45Gy and Dmax and 15.5% and 17.4% of the structure volume for bone marrow
V10Gy and V20Gy, respectively. Differences in other OAR dosimetric endpoints were observed
to decrease by 10.90%, 14.40% and 7.10% for Dmax of the rectum, Dmax of the bladder and
Dmax of the femoral head, respectively. The PTV coverage differed slightly between the under-
assessment plan and the SCORE re-optimized plan, with reductions of 0.50% and 0.10% for
V99 and V97, respectively, and the same was true for other dosimetric endpoints (data are
shown in the S1 Dataset, sheet “WilcoxonTestForPoorQualityPlans”). The overall p value for
the under-assessment plan and SCORE re-optimized plan dosimetric endpoint value array pair
was less than 0.05, showing a significant difference and indicating that the plan quality failed.
In this case, users could choose to replace the under-assessment plan with the SCORE re-
Fig 3. Scatter plot of p values obtained from clinical cervical cancer IMRT plans.
doi:10.1371/journal.pone.0149273.g003
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optimized plan or to adjust the under-assessment plan manually until the updated plan quality
was found to pass.
Fig 4. A QC report example for a poor-quality plan.
doi:10.1371/journal.pone.0149273.g004
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In the 4 QC reports derived from the 4 other poor-quality IMRT plans, the criteria that
were unsatisfactory in the dosimetric endpoints in the under-assessment plans became satisfac-
tory in the corresponding SCORE re-optimized plans without sacrificing other dosimetric end-
points, indicating both the possibility of improving the under-assessment plans and the high
accuracy of the TPS-QC tool. In total, the overall p value for each under-assessment plan and
SCORE re-optimized plan dosimetric endpoint value array pair was less than 0.05 (on average
0.016 ± 0.006) (detailed data could be seen in the S1 Dataset, sheet “WilcoxonTestForPoorQua-
lityPlans”), showing a significant difference and indicating that the plan quality failed.
Discussion
Current studies for plan quality control/assessment are mainly focused on previous knowl-
edge learning to correlate patient geometry and its potential plan dosimetry. The predicted
plan dosimetry (i.e., DVH) is then obtained by applying the correlation model to a new
patient geometry as a standard of the quality acceptable plan. Since correlations are more eas-
ily explored when learnt from similar plans, the experience-based methods conduce a model
exclusiveness for each tumor site or even institution. Unlike the experience-based model is
usually tumor site or even institution specific, the proposed re-optimization based TPS-QC
tool gives a more general solution that most of IMRT plans are applicative. In addition to
this, the re-optimization stratagem can also avoid the process of building up treatment plan
training databases, which would be a rigorous issue when cases are insufficient at some initial
stages.
No matter the experience-based method or the re-optimization stratagem, both of them can
help to establish a new standard of potential higher quality treatment plan, though in different
ways of either predicting optimal dosimetric goals or expanding the solution domain. As previ-
ously mentioned, the IMRT plan creation is mainly the process of searching optimal solutions
with a dose optimization algorithm within given dosimetric goals, consequently an idea high
quality standard is more favorably released by considering not only patient specific optimal tar-
get but also a possibly complete solution domain. Therefore, the experience-based method and
the re-optimization stratagem are not antipathetic but mutual that they should be combined to
collectively ensure cancer patient’s specific high quality treatment.
From these 25 assumed high quality clinically approved IMRT plans, one of them was tested
with significant difference and hence identified as with “failed” quality. After having this partic-
ular plan re-checked with our experienced dosimetrist, we found that no criterion is created for
neither the left femoral head nor the right femoral head. This caused that the Dmax of femoral
head obtained a remarkable improvement after further optimized by our TPS-QC tool, namely
from 98.5% to 66.5%, for original plan and the SCORE re-optimized plan respectively. Besides,
since a clinically approved IMRT plan is created from a complicated planning process, as previ-
ously mentioned, it is possible that few plans are generated with undesirable quality.
Though our developed plan quality control tool shew high consistency with the actual
IMRT plan quality, and can complete the whole evaluation process automatically, there remain
some limitations for further investigation and improvement. For instance, we incorporated a
two-stage automated voxel-weighting factor tuning strategy in the plan optimization, of which
the weighting factor tuning is a function of previously and currently DVH area difference.
Admitting that the weighting factor is fully automatically adjusted, the rule of adjustment is
intuitive. Underground scientific correlations behind is still not clear so far [34]. As a conse-
quence, not only the tuning method but also the iteration limit, which is set to restrict the itera-
tions for solving an optimization objective function, would be affected, thus impact the solving
accuracy and its efficiency.
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Our future work aims to apply the TPS-QC tool to other tumor sites for clinical use. Future
efforts will focus on tumor site-specific optimization and application improvements, including
enabling interactions with commercial TPSs and incorporating feedback from planners and
physicians. In addition, another challenging project is to take the potential QA failures into
account so that the optimized higher quality plan could be ensured. Although the leaf sequenc-
ing has already been considered and the dose engine (FSPB) has been customized to the com-
mercial TPS at the current stage, more improvements should be made, such as considering
more machine limitations during the leaf transmission and incorporating the Monte Carlo
dose calculation algorithm into the SCORE system.
Conclusions
In this work, we practically apply a voxel-weighting factor-based plan re-optimization method
to perform treatment plan quality control. Based on this approach, we integrated a highly auto-
mated and potentially clinically useful IMRT plan QC tool. The feasibility and accuracy of the
proposed TPS-QC tool were verified using 25 clinically approved cervical cancer patient IMRT
plans and 5 poor-quality IMRT plans. The integrated TPS-QC tool is user-friendly and easy to
operate. In addition, the under-assessment plan QC report can be created automatically within
2 minutes of being imported. Furthermore, the TPS-QC tool can generate a corresponding re-
optimized plan that can replace the failed under-assessment plan. This replacement can not
only help improve treatment plan quality but also reduce the manual effort needed to adjust
the plan, thereby laying the foundation for the application of the TPS-QC tool in clinics.
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